Abstract:Background: Cerebral cavernous malformations (CCMs) are vascular disorders with a diverse natural history causing stroke and epilepsy. This multicenter cohort study aimed to unravel the correlation between genotype and clinical presentation in CCMs. Methods: We conducted a multicenter cohort study across three reference centers in China. In this study, we employed whole-exome sequencing, droplet digital PCR, and targeted panel sequencing to analyze 290 surgical specimens of CCMs. We also conducted an observational study of patients managed conservatively prior to surgical resection of CCMs to elucidate their natural history. Findings: Between January 2013 and May 2023, 201 out of 290 surgically resected CCMs had mutations in MAP3K3, PIK3CA, or CCM germline mutations, and were subsequently included in further analysis. Patients with solitary PIK3CA mutations exhibited a higher likelihood of hemorrhage (P < .001), while those with MAP3K3 mutations were more prone to epilepsy onset (P < .001). The mutation spectrum correlated with various clinical parameters, influencing hemorrhage risk (P < .001), lesion diameter (P = .020), onset of non-hemorrhage epilepsy (P < .001), Zabramski classifications (P < .001), DVA (P < .001) and edema in the MRI appearance (P < .001). Over the study period, patients with PIK3CA mutations showed significantly higher 1-, 2-, and 5-year cumulative risks of hemorrhage (34.8%, 51.7%, and 62.7%, respectively) higher cumulative risks of hemorrhage compared to MAP3K3 mutations (P < .017) and double mutations (P < .001). Adjusted analyses confirmed the increased risk of subsequent hemorrhage in patients with PIK3CA mutations (adjusted HR = 8.816, 95% CI: 1.478-9.855, P = .045). Independent risk factors for epilepsy included age of onset (adjusted OR = 0.956, 95% CI: 0.928-0.983, P = .002), lesion diameter (adjusted OR= 0.545, 95% CI: 0.325-0.914, P = .021), and lesion locations (adjusted OR = 0.545, 95% CI: 0.325-0.914, P < .001). Notably, patients with germline mutations experienced earlier symptom onset (P = .003) and larger lesions (P = .019) compared to those with somatic mutations. Interpretation: This study's findings highlight a significant correlation between CCM genotype and clinical phenotypes, particularly regarding hemorrhage risk and seizures. The results offer insights into predicting the clinical course of CCM patients with different phenotypes, potentially leading to personalized treatment adjustments.Funding: National Natural Science Foundation of China (No. 82220108010, 81971104, 82201440, 82122020, 82101369, 82102009 and 82330038). Beijing Municipal Commission of Education (BPHR20220113).Declaration of Interest: Tao Hong, Hongqi Zhang, Jian Ren report grants from National Natural Science Foundation of China. Tao Hong reports grants from Beijing Municipal Commission of Education. Hongqi Zhang, and Tao Hong declare no competing interests.Ethical Approval: This study was conducted in compliance with the approval of the local ethics committee and involved a prospectively maintained database. Furthermore, all patients provided informed consent, or consent was obtained from their legal guardian in cases involving participants with cognitive impairment or those aged younger than 18 years.

Genetic landscape of common venous malformations in the head and neck

Progress in the Genetics Research of Infantile Hemangioma and Vascular Malformations

Genotypes and phenotypes of capillary malformation–arteriovenous malformation: characterization and correlation analysis

Mutational Spectrum of Syndromic Genes in Sporadic Brain Arteriovenous Malformation

Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.

Current Understanding of the Genetics of Extracranial Arteriovenous Malformation

Update on the Molecular Genetics of Vascular Anomalies

Review of the Endothelial Pathogenic Mechanism of TIE2-related Venous Malformation.

Somatic loss-of-function PIK3R1 and activating non-hotspot PIK3CA mutations associated with Capillary Malformation with Dilated Veins (CMDV)

Exome sequencing of 112 trios identifies recessive genetic variants in brain arteriovenous malformations

Genetic mutations and phenotype characteristics in peripheral vascular malformations: A systematic review

Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations

Venous Malformations: Diagnosis, Management, and Future Directions

Perturbations of BMP/TGF-β and VEGF/VEGFR Signalling Pathways in Non-Syndromic Sporadic Brain Arteriovenous Malformations (BAVM)

Association Study Between of Tie2/Angiopoietin-2 and VEGF/KDR Pathway Gene Polymorphisms and Vascular Malformations

Next-generation Sequencing Identifies Novel Genes with Rare Variants in Total Anomalous Pulmonary Venous Connection

Non‐Hotspot PIK3CA Variants Have Higher Variant Allele Frequency and are More Common in Syndromic Vascular Malformations

Updates in Genetic Testing for Head and Neck Vascular Anomalies

Genotype–Phenotype and Genotype–Outcome Analysis of Capillary Malformation–Arteriovenous Malformation

Transcriptional data analysis reveals the association between infantile hemangiomas and venous malformations

Correlation of Genotype and Clinical Phenotype in Cerebral Cavernous Malformations: A Multicenter Cohort Study